Editorial
Main Author: | Mario Cazzola |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2007-10-01
|
Series: | Therapeutic Advances in Respiratory Disease |
Online Access: | https://doi.org/10.1177/1753465807081457 |
Similar Items
-
Molecular genetics in clinical decision making for patients with myelodysplastic syndromes or related disorders
by: Mario Cazzola
Published: (2018-06-01) -
The divergent opinions of regulatory authorities on roflumilast are puzzling but we need new drugs for treating chronic obstructive pulmonary disease
by: Mario Cazzola
Published: (2010-08-01) -
From large clinical trials to management of COPD in the real world
by: Mario Cazzola
Published: (2009-02-01) -
Cough and asthma: the role of inhaled corticosteroids and ß2-agonists
by: Mario Cazzola, et al.
Published: (2008-02-01) -
Long-acting β2-agonists (LABA) in chronic obstructive pulmonary disease: efficacy and safety
by: Andrea Rossi, et al.
Published: (2008-07-01)